•  
  •  
 

Journal of Scientific Information Research

Keywords

antitumor drugs; innovation source ability; patent information; patent analysis

Abstract

[Purpose/significance]Through the analysis of Shanghai's anti-tumor drug patent information,it provides valuable decision-making and strategic support for the implementation of innovative activities and future development of the Shanghai biomedical industry.[Method/process]Carry out information mining and description of Shanghai's anti-cancer drug patents,and explore the innovation capabilities of Shanghai's anti-cancer drugs from the three aspects of high-level patents,scientific innovation community,and patent achievement transformation,and understand the development context of innovation strategies.[Result/conclusions The research results show that to improve Shanghai's scientific and technological innovation ability,it is necessary to increase high-level patent output,coordinate the development of regional innovation communities,improve the transformation of patent achievements,and provide effective guarantees for technological innovation.

First Page

94

Last Page

102

Submission Date

17-Aug-2020

Revision Date

16-Nov-2020

Published Date

01-Jan-2021

Reference

[1] 上海市人民政府新闻办公室. 上海加快建设具有全球影响力的科技创新中心五年以来的主要进展 [DB/OL]. (2019-05-21) [2020-08-17] http://www.shio.gov.cn/sh/xwb/n790/n792/n1070/n1079/u1ai21124.html.
[2] 李杨, 唐克. 全球主要经济体技术创新及对我国的启示: 基于PCT申请视角 [J]. 征信, 2020, 38(08): 11-17, 92.
[3] 陈超. 如何理解创新策源能力 [J]. 竞争情报, 2018,14(04): 3.
[4] 任声策. 以 "源" 促 "策", 全面增强创新策源能力 [N]. 科技日报, 2020-03-24(005).
[5] 朱梦菲, 陈守明, 邵悦心. 基于AHP-TOPSIS和SOM聚类的区域创新策源能力评价 [J]. 科研管理, 2020, 41 (02): 40-50.
[6] 冯海刚. 从专利角度分析和展望我国固体废物产业的技术创新 [J]. 中国发明与专利, 2020, 17(06): 70-77.
[7] 黄辛, 胡璇子. 15大城市科技创新策源点出炉 [J]. 中国科技奖励, 2019(06): 70-72.
[8] 江胜强, 田培培, 沙子墨, 等. 基于合作发明专利的我国生物医药领域研发合作现状分析 [J]. 中国药房, 2017, 28(31): 4334-4337.
[9] 戈一冰, 马路. 基于专利视角的我国高等医学院校科技创新能力分析 [J].中华医学图书情报杂志, 2019, 28(04): 10-15.
[10] 李悦, 高欢, 金芳, 等. 多肽类化合物抗肿瘤作用机制的研究进展 [J]. 医学综述, 2019, 25(17): 3486-3490, 3496.
[11] 代月函, 杨琳琳, 靳春鹏, 等. 抗CD47抗体、多肽类抗肿瘤药物专利发展状况分析 [J]. 中国新药杂志, 2019, 28(19): 2305-2311.

Download

Share

COinS